Literature DB >> 10903762

Inhibition of human endothelial cell chemokine production by the opportunistic fungal pathogen Cryptococcus neoformans.

N Mozaffarian1, A Casadevall, J W Berman.   

Abstract

Cryptococcus neoformans is an encapsulated fungal pathogen commonly acquired by inhalation. Extrapulmonary dissemination can lead to infection of the bloodstream and various organs, most commonly resulting in meningoencephalitis. However, infection with C. neoformans is often characterized by a scant inflammatory response. The leukocyte response to infection depends in part upon a gradient of chemotactic factors and adhesion molecules expressed by the host vascular endothelium, yet the inflammatory response of human endothelial cells (EC) to C. neoformans has not been previously investigated. We found that incubation of primary human EC with C. neoformans did not induce chemokine synthesis, and resulted in differential inhibition of cytokine-induced IL-8, IFN-gamma-inducible protein-10, and monocyte chemoattractant protein-1. In contrast, C. neoformans had little effect on EC surface expression of the leukocyte ligand, ICAM-1, as determined by flow cytometry. Modulation of chemokine production was dependent on the chemokine under study, the inoculum of C. neoformans used, fungal viability, and cell-cell contact, but independent of cryptococcal strain or encapsulation. These observations suggest a novel mechanism whereby C. neoformans can affect EC function and interfere with the host inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903762     DOI: 10.4049/jimmunol.165.3.1541

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Molecular machinations: chemokine signals in host-pathogen interactions.

Authors:  S W Chensue
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Inhibition of PMA-induced endothelial cell activation and adhesion by over-expression of domain negative IkappaBalpha protein.

Authors:  Jian-Feng Wei; Ke Sun; Shi-Guo Xu; Hai-Yang Xie; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

3.  Inhibition of interleukin-8 production in human endothelial cells by Staphylococcus aureus supernatant.

Authors:  A Tajima; K Seki; H Shinji; S Masuda
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

4.  Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection.

Authors:  B C Fries; C P Taborda; E Serfass; A Casadevall
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

5.  Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins.

Authors:  M C Noverr; S M Phare; G B Toews; M J Coffey; G B Huffnagle
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  Surface localization of the Yps3p protein of Histoplasma capsulatum.

Authors:  Megan L Bohse; Jon P Woods
Journal:  Eukaryot Cell       Date:  2005-04

7.  Effect of the antioxidant alpha-lipoic acid on apoptosis in human umbilical vein endothelial cells induced by high glucose.

Authors:  X Meng; Z M Li; Y J Zhou; Y L Cao; J Zhang
Journal:  Clin Exp Med       Date:  2008-04-03       Impact factor: 3.984

8.  Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion.

Authors:  Michal A Olszewski; Mairi C Noverr; Gwo-Hsiao Chen; Galen B Toews; Gary M Cox; John R Perfect; Gary B Huffnagle
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

9.  Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans.

Authors:  Caroline Charlier; Kirsten Nielsen; Samira Daou; Madly Brigitte; Fabrice Chretien; Françoise Dromer
Journal:  Infect Immun       Date:  2008-10-20       Impact factor: 3.441

10.  Leishmania promastigotes release a granulocyte chemotactic factor and induce interleukin-8 release but inhibit gamma interferon-inducible protein 10 production by neutrophil granulocytes.

Authors:  G van Zandbergen; N Hermann; H Laufs; W Solbach; T Laskay
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.